Vicarious Surgical (RBOT) Non-Current Deferred Tax Liability (2021)

Vicarious Surgical's (RBOT) quarterly Non-Current Deferred Tax Liability came in at $1.4 million in Q4 2021.

Vicarious Surgical (RBOT) Non-Current Deferred Tax Liability (2021) Analysis & Trends

Vicarious Surgical (RBOT) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $1.4 million in Q4 2021.

On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.4 million in Q4 2021; TTM through Dec 2021 was $1.4 million, a N/A change from a year earlier, with the FY2021 full-year figure at $1.4 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability for Q4 2021 stood at $1.4 million.
Over the last five years, Non-Current Deferred Tax Liability for RBOT reached as high as $1.4 million in Q4 2021 and fell as low as $1.4 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Vicarious Surgical	654,984.55	-9.14 Mn	-

Download Data

Date	Value
Dec 31, 2021	1.40 Mn
Dec 31, 2021	1.40 Mn